Document ID: chunk:federal_register_of_legislation:F2022C00927:reg:9:p3
Version: federal_register_of_legislation:F2022C00927
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 10747–12804

the clinical worsening of conjunctivitis;
         (28)      taking a drug from the specified list of drugs for at least the seven days before the clinical worsening of conjunctivitis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
         (29)      taking a drug which is associated in the individual with:
            (a)          the worsening of conjunctivitis during drug therapy; and
            (b)          the improvement of conjunctivitis within seven days of discontinuing or tapering drug therapy;
         where treatment with the drug continued for at least the seven days before the clinical worsening of conjunctivitis;
         (30)      having ocular or periocular exposure to an irritant substance within the 24 hours before the clinical worsening of conjunctivitis;
Note: irritant substance is defined in the Schedule 1 - Dictionary.
         (31)      having mustard gas exposure to the affected eye within the 24 hours before the clinical worsening of conjunctivitis;
         (32)      having a foreign body in contact with the affected conjunctiva within the 24 hours before the clinical worsening of conjunctivitis;
         (33)      having an injury to the conjunctiva of the affected eye within the 24 hours before the clinical worsening of conjunctivitis;
Note: injury to the conjunctiva is defined in the Schedule 1 - Dictionary.
         (34)      undergoing a course of therapeutic radiation for cancer, where the region of the affected eye was in the field of radiation, at the time of the clinical worsening of conjunctivitis;
         (35)      having a benign or malignant neoplasm affecting the conjunctiva or eyelid margin of the affected eye at the time of the clinical worsening of conjunctivitis;
         (36)      being in an immunocompromised state as specified at the time of the clinical worsening of conjunctivitis;
Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.
(37)      inability to obtain appropriate clinical management for conjunctivitis.